How to get value from an FDA public meeting

FDA does a meaningful share of its work in public. Advisory committee meetings, public workshops, listening sessions on a draft guidance — these are open, and sometimes even open to speak at, and a lot of early-career professionals treat them as either irrelevant or as a backdoor to feedback on their own submission. Neither read is right. Figuring out which meetings are worth your time, and what to actually do once you are in the room, is its own skill.

What these meetings actually are

An advisory committee meeting convenes a panel of outside experts — clinicians, scientists, sometimes a patient representative — to advise FDA on a specific product or scientific question, often ahead of a major approval decision. The meeting is open to public observation, and it typically includes an open public hearing portion where members of the public may sign up in advance to speak, within a strict per-speaker time limit. A public workshop is a different animal: usually FDA staff walking through a program or a guidance document in development, structured more like an extended Q&A than a formal hearing.

Both are different in kind from a Pre-Submission meeting, which is private, scheduled specifically for your device, and where the discussion is actually about your data. A public meeting is not that, and treating it like a private one — showing up expecting reviewers to engage with your specific product — is the fastest way to leave disappointed.

How you find out one is happening

Meetings are announced through a notice in the Federal Register, which states the date, time, subject, the docket number, how to register to attend, and — when an open public hearing is part of the agenda — the deadline to request time to speak or to submit materials in advance. The docket itself, usually reachable through regulations.gov, stays open for written comment for a defined period that often extends past the meeting date, which means you do not have to be in the room to put something on the record.

What “getting on the agenda” actually means

For an open public hearing, the sign-up deadline in the notice is real. It typically asks for a short written request describing what you intend to say, submitted well ahead of the meeting, and it comes with a hard per-speaker time limit that is usually a matter of minutes, not a conversation. Showing up on the day and expecting to be called on is not how this works. A written comment filed to the docket, by contrast, does not require a speaking slot at all and becomes part of the record either way — often the more useful move if what you have to say does not need to be said out loud.

The meetings worth your time as an early-career professional are usually not the ones with the highest profile — a landmark advisory committee panel draws a crowd for a reason, but a modest workshop on a template or a program you actually use will teach you more, faster, and put you in a room with the people who wrote it. That kind of unglamorous exposure is also just how a professional network gets built in this field: not through a single big event, but through showing up prepared often enough that people start to recognize the question you ask.